| 000 | 01782 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515175642.0 | ||
| 264 | 0 | _c20091224 | |
| 008 | 200912s 0 0 eng d | ||
| 022 | _a1535-3893 | ||
| 024 | 7 |
_a10.1021/pr9004103 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPatterson, Andrew D | |
| 245 | 0 | 0 |
_aHuman urinary metabolomic profile of PPARalpha induced fatty acid beta-oxidation. _h[electronic resource] |
| 260 |
_bJournal of proteome research _cSep 2009 |
||
| 300 |
_a4293-300 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aArtificial Intelligence |
| 650 | 0 | 4 |
_aBiomarkers _xurine |
| 650 | 0 | 4 |
_aCarnitine _xanalogs & derivatives |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aFatty Acids _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFenofibrate _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMass Spectrometry |
| 650 | 0 | 4 |
_aMetabolome _xdrug effects |
| 650 | 0 | 4 |
_aMetabolomics _xmethods |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aPPAR alpha _xurine |
| 650 | 0 | 4 |
_aPantothenic Acid _xurine |
| 650 | 0 | 4 |
_aUrine _xchemistry |
| 700 | 1 | _aSlanar, Ondrej | |
| 700 | 1 | _aKrausz, Kristopher W | |
| 700 | 1 | _aLi, Fei | |
| 700 | 1 | _aHöfer, Constance C | |
| 700 | 1 | _aPerlík, Frantisek | |
| 700 | 1 | _aGonzalez, Frank J | |
| 700 | 1 | _aIdle, Jeffrey R | |
| 773 | 0 |
_tJournal of proteome research _gvol. 8 _gno. 9 _gp. 4293-300 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/pr9004103 _zAvailable from publisher's website |
| 999 |
_c18986330 _d18986330 |
||